Medical Equipment

High flow nasal cannula Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

March 12, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The High flow nasal cannula Market Over The Period 2026–2030?

The high flow nasal cannula market size has experienced robust growth in recent years. It is projected to increase from $6.22 billion in 2025 to $6.79 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. The expansion observed in the historical period can be attributed to the rising incidence of respiratory disorders, an increase in hospital admissions for acute respiratory failure, the implementation of high-flow oxygen therapy protocols, the development of intensive care infrastructure, and a growing clinical understanding of the benefits of HFNC.

The high flow nasal cannula market is anticipated to experience substantial expansion over the coming years, with its size projected to reach $9.64 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This projected growth is primarily driven by factors such as the increasing deployment of HFNC in home care environments, a heightened demand for portable respiratory support equipment, the broadening scope of respiratory care provisions, an intensified emphasis on therapies for early intervention, and continuous technological progress in airflow and humidification systems. Key developments expected during this forecast period encompass the wider embrace of sophisticated heated humidification systems, increased application of HFNC in acute care environments, a growing inclination towards non-invasive oxygen therapy, the proliferation of portable and home-based HFNC solutions, and an enhanced focus on ensuring patient comfort and adherence to treatment.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13454&type=smp

Which Major Factors Are Driving The Expansion Of The High flow nasal cannula Market?

The increasing incidence of asthma and chronic obstructive pulmonary disease (COPD) is anticipated to drive the expansion of the high-flow nasal cannula market in the coming years. Asthma is a condition characterized by the constriction and swelling of airways in the lungs, along with excessive mucus production. chronic obstructive pulmonary disease (COPD) refers to a group of lung diseases that impede breathing and progressively worsen over time. A high-flow nasal cannula offers the capability to enhance PO2 while simultaneously reducing HR and RR, positioning it as a practical treatment alternative for patients with severe bronchial Asthma exacerbated by respiratory failure. This device contributes to managing the rising number of asthma and COPD cases by improving oxygenation and mitigating respiratory distress in affected individuals. For example, in December 2023, a research study featured in JAMA Network Open, a medical journal published by the American Medical Association, forecasted that the global prevalence of chronic obstructive pulmonary disease (COPD) could result in nearly 600 million cases worldwide by 2050, signifying a 23% increase in its prevalence. Therefore, the escalating incidence of asthma and chronic obstructive pulmonary disease (COPD) is a key driver for the high-flow nasal cannula market.

How Is The High flow nasal cannula Market Divided Into Its Major Segments?

The high flow nasal cannula market covered in this report is segmented –

1) By Type: Air Or Oxygen Blenders, Nasal Cannulas, Active Humidifier, Single Heated Tube, Other Types

2) By Application: Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Carbon Monoxide Toxicity, Bronchiectasis, Sleep Apnea, Other Applications

3) By Sales Channel: Direct Channel, Distribution Channel

4) By End-User: Hospitals and clinics, Ambulatory care centers, Long-term care centers, Other End-Users

Subsegments:

1) By Air or Oxygen Blenders: Manual Oxygen Blenders, Digital Oxygen Blenders

2) By Nasal Cannulas: Adult Nasal Cannulas, Pediatric Nasal Cannulas

3) By Active Humidifier: Heated Active Humidifiers, Non-Heated Active Humidifiers

4) By Single Heated Tube: Single Heated Tubes For Adult Use, Single Heated Tubes For Pediatric Use

5) By Other Types: Disposable High Flow Nasal Cannulas, Non-Invasive Ventilation (NIV) Interfaces

How Are Trends Transforming The High flow nasal cannula Market Landscape?

Leading companies operating within the high-flow nasal cannula market are concentrating on advanced products, such as the SoftFlow High-Flow Nasal Cannula, to serve their existing consumers. The SoftFlow High-Flow Nasal Cannula functions as a breathing assistance device, utilizing a nasal cannula to supply patients with warm, humidified, oxygen-enriched oxygen. For instance, in 2024, Fisher & Paykel Healthcare, a New Zealand-based manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea, launched the Airvo 2 device, which forms part of the Optiflow Nasal High Flow Therapy system. This system delivers heated, humidified air and oxygen at high flow rates, which assists in improving oxygenation and reducing the work of breathing for patients with COVID-19 and other respiratory conditions. Its optimal humidity levels preserve mucociliary function and decrease airway dryness, thereby enhancing patient comfort. Additionally, the device is simple to set up and use, making it suitable for various hospital settings and leading to improved clinical outcomes.

Who Are The Prominent Organizations Shaping The High flow nasal cannula Market?

Major companies operating in the high flow nasal cannula market are Air Liquide Medical Systems Pvt. Ltd., Becton Dickinson and Company, Koninklijke Philips N.V., ResMed Inc., Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Medical Dynamics Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical Inc., Vyaire Medical Inc., DeVilbiss Healthcare LLC, Armstrong Medical Ltd, Vapotherm Inc., SunMed LLC, Medin Medical Innovations GmbH, MEK-ICS Co. Ltd., Narang Medical Limited, Breas Medical AB, Bio-Med Devices Inc., Flexicare Medical Ltd., Fairmont Medical Products Pty Ltd, Besmed Health Business Corp., Löwenstein GmbH & Co. KG, Great Group Medical Co. Ltd., TNI Medical AG, Guangdong Pigeon Medical Apparatus Co.LTD, BLS Systems Limited

Read the full high flow nasal cannula market report here:

https://www.thebusinessresearchcompany.com/report/high-flow-nasal-cannula-global-market-report

Which Region Currently Holds The Largest Share Of The High flow nasal cannula Market?

North America was the largest region in the high flow nasal cannula market in 2025. The regions covered in the high flow nasal cannula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored High flow nasal cannula Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13454&type=smp

Browse Through More Reports Similar to the Global High flow nasal cannula Market 2026, By The Business Research Company

Nasal Drug Delivery Technology Market Report 2026

https://www.thebusinessresearchcompany.com/report/nasal-drug-delivery-technology-global-market-report

Internal Nasal Dilators Market Report 2026

https://www.thebusinessresearchcompany.com/report/internal-nasal-dilators-global-market-report

Inhalation And Nasal Spray Generic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalation-and-nasal-spray-generic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795